SCHEMBL30255028

SCHEMBL30255028

CCOC(=O)c1cnn2cnc(N[C@H](C)c3cccnc3OC)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ TGFBR1 P36897 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ MAP4K4 O95819 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23500992 0.83 TGFBR1 (0.48) HPGDNPC1RAB9ATP53ALDH1A1
SCHEMBL29989315 0.83 TGFBR1 (0.48) HPGDNPC1RAB9ATP53ALDH1A1
SCHEMBL23500995 0.83 TGFBR1 (0.48) HPGDNPC1RAB9ATP53ALDH1A1
SCHEMBL23501055 0.77 TGFBR1 (0.46) HPGDNPC1RAB9ATP53ALDH1A1
SCHEMBL23501053 0.77 TGFBR1 (0.46) HPGDNPC1RAB9ATP53ALDH1A1
SCHEMBL30254901 0.73 ELANE (0.35) HPGDNPC1RAB9ATP53ALDH1A1
SCHEMBL23501007 0.72 AAK1 (0.42) TGFBR1
SCHEMBL23501010 0.72 AAK1 (0.42) TGFBR1
SCHEMBL18361533 0.71 NTRK1 (0.46) TGFBR1
SCHEMBL18045155 0.70 TGFBR1 (0.46) HPGDNPC1RAB9ATP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12428433-B2 Fluorine-containing heterocyclic derivatives with macrocyclic structure and use thereof SCINNOHUB PHARMACEUTICAL CO., LTD (CN) 2025-09-30 — — US disclosed
US-20230044722-A1 FLUORINE-CONTAINING HETEROCYCLIC DERIVATIVES WITH MACROCYCLIC STRUCTURE AND USE THEREOF SCINNOHUB PHARMACEUTICAL CO., LTD. (CN) 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428433-B2 Fluorine-containing heterocyclic derivatives with macrocyclic structure and use thereof FRK, BRAF, ERBB3 HPGD 3775/4885NPC1 921/4885RAB9A 1505/4885
US-20230044722-A1 FLUORINE-CONTAINING HETEROCYCLIC DERIVATIVES WITH MACROCYCLIC STRUCTURE AND USE THEREOF FRK, BRAF, ERBB3 HPGD 3775/4885NPC1 921/4885RAB9A 1505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback